BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 25298119)

  • 1. Management of non-cognitive symptoms associated with dementia.
    Drug Ther Bull; 2014 Oct; 52(10):114-8. PubMed ID: 25298119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
    Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
    J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
    [No Abstract]   [Full Text] [Related]  

  • 3. How safe are antipsychotics in dementia?
    BMJ Group
    Drug Ther Bull; 2007 Nov; 45(11):81-5. PubMed ID: 18165678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].
    Ruths S; Straand J
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1672-5. PubMed ID: 15976839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms.
    Azermai M; Petrovic M; Elseviers MM; Bourgeois J; Van Bortel LM; Vander Stichele RH
    Ageing Res Rev; 2012 Jan; 11(1):78-86. PubMed ID: 21856452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.
    Greenblatt HK; Greenblatt DJ
    J Clin Pharmacol; 2016 Sep; 56(9):1048-57. PubMed ID: 26953213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of behavioural and psychological disturbance in dementia.
    Kozman MN; Wattis J; Curran S
    Hum Psychopharmacol; 2006 Jan; 21(1):1-12. PubMed ID: 16389667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
    Gareri P; De Fazio P; Manfredi VG; De Sarro G
    J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
    Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
    J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics and dementia: where do we go from here?
    Blazer DG
    J Am Med Dir Assoc; 2013 Apr; 14(4):307-8. PubMed ID: 23415842
    [No Abstract]   [Full Text] [Related]  

  • 12. Difficult behaviors in long-term care patients with dementia.
    Buhr GT; White HK
    J Am Med Dir Assoc; 2007 Mar; 8(3 Suppl 2):e101-13. PubMed ID: 17352973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.
    Beier MT
    Am J Health Syst Pharm; 2007 Jan; 64(2 Suppl 1):S9-17; quiz S24-5. PubMed ID: 17215476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment alternatives of severe behavioral symptoms].
    Koponen H
    Duodecim; 1999; 115(15):1629-33. PubMed ID: 11912754
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature.
    Snowden M; Sato K; Roy-Byrne P
    J Am Geriatr Soc; 2003 Sep; 51(9):1305-17. PubMed ID: 12919245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors.
    Rios S; Perlman CM; Costa A; Heckman G; Hirdes JP; Mitchell L
    BMC Geriatr; 2017 Oct; 17(1):244. PubMed ID: 29061129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
    Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
    Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Bertolucci PH; Chen ES; Smith Mde A
    J Neurol Sci; 2014 Jan; 336(1-2):103-8. PubMed ID: 24189208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
    Sturm AS; Trinkley KE; Porter K; Nahata MC
    Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment of behavioral symptoms in dementia patients].
    Gabryelewicz T
    Przegl Lek; 2014; 71(4):215-20. PubMed ID: 25141581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.